Human Insulin Resistance Is Associated With Increased Plasma Levels of 12α-Hydroxylated Bile Acids

Bile acids (BAs) exert pleiotropic metabolic effects, and physicochemical properties of different BAs affect their function. In rodents, insulin regulates BA composition, in part by regulating the BA 12α-hydroxylase CYP8B1. However, it is unclear whether a similar effect occurs in humans. To address this question, we examined the relationship between clamp-measured insulin sensitivity and plasma BA composition in a cohort of 200 healthy subjects and 35 type 2 diabetic (T2D) patients. In healthy subjects, insulin resistance (IR) was associated with increased 12α-hydroxylated BAs (cholic acid, deoxycholic acid, and their conjugated forms). Furthermore, ratios of 12α-hydroxylated/non–12α-hydroxylated BAs were associated with key features of IR, including higher insulin, proinsulin, glucose, glucagon, and triglyceride (TG) levels and lower HDL cholesterol. In T2D patients, BAs were nearly twofold elevated, and more hydrophobic, compared with healthy subjects, although we did not observe disproportionate increases in 12α-hydroxylated BAs. In multivariate analysis of the whole dataset, controlling for sex, age, BMI, and glucose tolerance status, higher 12α-hydroxy/non–12α-hydroxy BA ratios were associated with lower insulin sensitivity and higher plasma TGs. These findings suggest a role for 12α-hydroxylated BAs in metabolic abnormalities in the natural history of T2D and raise the possibility of developing insulin-sensitizing therapeutics based on manipulations of BA composition.

[1]  Gabi Kastenmüller,et al.  Early Metabolic Markers of the Development of Dysglycemia and Type 2 Diabetes and Their Physiological Significance , 2013, Diabetes.

[2]  F. Schütz,et al.  Hepatic glucose sensing is required to preserve β cell glucose competence. , 2013, The Journal of clinical investigation.

[3]  Barbara Gross,et al.  Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease , 2012, Journal of Lipid Research.

[4]  F. Gonzalez,et al.  Bile Acids Acutely Stimulate Insulin Secretion of Mouse β-Cells via Farnesoid X Receptor Activation and KATP Channel Inhibition , 2012, Diabetes.

[5]  A. Groen,et al.  Bile acid sequestrants: more than simple resins , 2012, Current opinion in lipidology.

[6]  D. Accili,et al.  Impaired generation of 12-hydroxylated bile acids links hepatic insulin signaling with dyslipidemia. , 2012, Cell metabolism.

[7]  E. Oetjen Body Weight, Not Insulin Sensitivity or Secretion, May Predict Spontaneous Weight Changes in Nondiabetic and Prediabetic Subjects: The RISC Study , 2012 .

[8]  M. Walker,et al.  Influence of Hyperinsulinemia and Insulin Resistance on In Vivo β-Cell Function , 2011, Diabetes.

[9]  M. Walker,et al.  In fl uence of Hyperinsulinemia and Insulin Resistance on In Vivo b -Cell Function Their Role in Human b -Cell Dysfunction , 2011 .

[10]  Christian Gieger,et al.  Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting , 2010, PloS one.

[11]  F. Kuipers,et al.  Improved glycemic control with colesevelam treatment in patients with type 2 diabetes is not directly associated with changes in bile acid metabolism , 2010, Hepatology.

[12]  S. Woods,et al.  Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbidities. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[13]  D. Accili,et al.  Hepatic FoxO1 Ablation Exacerbates Lipid Abnormalities during Hyperglycemia* , 2010, The Journal of Biological Chemistry.

[14]  S. Fiorucci,et al.  The bile acid sensor FXR regulates insulin transcription and secretion. , 2010, Biochimica et biophysica acta.

[15]  A. Moschetta,et al.  Deciphering the nuclear bile acid receptor FXR paradigm , 2010, Nuclear receptor signaling.

[16]  J. Chiang,et al.  Bile acids: regulation of synthesis , 2009, Journal of Lipid Research.

[17]  J. Holst,et al.  Serum Bile Acids Are Higher in Humans With Prior Gastric Bypass: Potential Contribution to Improved Glucose and Lipid Metabolism , 2009, Obesity.

[18]  P. Dent,et al.  Bile acids as regulatory molecules , 2009, Journal of Lipid Research.

[19]  Beverley Balkau,et al.  Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population , 2009, Hepatology.

[20]  T. Osborne,et al.  FGF15/FGFR4 Integrates Growth Factor Signaling with Hepatic Bile Acid Metabolism and Insulin Action* , 2009, Journal of Biological Chemistry.

[21]  B. Staels,et al.  Role of bile acids and bile acid receptors in metabolic regulation. , 2009, Physiological reviews.

[22]  Johan Auwerx,et al.  Targeting bile-acid signalling for metabolic diseases , 2008, Nature Reviews Drug Discovery.

[23]  C. Kahn,et al.  Hepatic insulin resistance directly promotes formation of cholesterol gallstones , 2008, Nature Medicine.

[24]  Margaret F. Gregor,et al.  Thematic review series: Adipocyte Biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease Published, JLR Papers in Press, May 9, 2007. , 2007, Journal of Lipid Research.

[25]  Margaret F. Gregor,et al.  Adipocyte stress: the endoplasmic reticulum and metabolic disease , 2007 .

[26]  D. Accili,et al.  FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. , 2005, Cell metabolism.

[27]  Jesse D. Martinez,et al.  Bile acid induces hydrophobicity-dependent membrane alterations. , 2005, Biochimica et biophysica acta.

[28]  B. Staels,et al.  Glucose regulates the expression of the farnesoid X receptor in liver. , 2004, Diabetes.

[29]  N. de Pedro,et al.  The Farnesoid X Receptor Controls Gene Expression in a Ligand- and Promoter-selective Fashion* , 2004, Journal of Biological Chemistry.

[30]  M. Walker,et al.  The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and Objectives , 2004, Diabetologia.

[31]  S. Tazuma,et al.  Feeding natural hydrophilic bile acids inhibits intestinal cholesterol absorption: studies in the gallstone-susceptible mouse. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[32]  U. Beuers,et al.  Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisited , 2002, Hepatology.

[33]  B. Aronow,et al.  Independent and overlapping transcriptional activation during liver development and regeneration in mice , 2002, Hepatology.

[34]  A. Hofmann,et al.  The continuing importance of bile acids in liver and intestinal disease. , 1999, Archives of internal medicine.

[35]  M. Makishima,et al.  Identification of a nuclear receptor for bile acids. , 1999, Science.

[36]  J. Lehmann,et al.  Bile acids: natural ligands for an orphan nuclear receptor. , 1999, Science.

[37]  A Mari,et al.  How to measure insulin sensitivity , 1998, Journal of hypertension.

[38]  H. Kurihara,et al.  Altered bile acid metabolism related to atherosclerosis in alloxan diabetic rats. , 1996, Journal of atherosclerosis and thrombosis.

[39]  D. Heuman Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. , 1989, Journal of lipid research.

[40]  T. Akiyoshi,et al.  Cholesterol gallstones in alloxan-diabetic mice. , 1986, Journal of lipid research.

[41]  T. Akiyoshi,et al.  Altered Bile Acid Metabolism in Nonobese, Spontaneously Diabetic (NOD) Mice , 1985, Diabetes.

[42]  A. Hofmann,et al.  Physicochemical properties of bile acids and their relationship to biological properties: an overview of the problem. , 1984, Journal of lipid research.

[43]  D. Billington,et al.  Effects of bile salts on the plasma membranes of isolated rat hepatocytes. , 1980, The Biochemical journal.

[44]  R. Coleman,et al.  Effects of different bile salts upon the composition and morphology of a liver plasma membrane preparation. Deoxycholate is more membrane damaging than cholate and its conjugates. , 1977, Biochimica et biophysica acta.